Overview

Metformin Treatment of Patients with Hand Osteoarthritis

Status:
RECRUITING
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
To compare metformin (2 g daily), or maximum tolerated dose, for 16 weeks with placebo as a treatment of hand osteoarthritis symptoms.
Phase:
PHASE3
Details
Lead Sponsor:
Marius Henriksen
Treatments:
Metformin